A case of factor V inhibitor with complete correction of the PT and aPTT upon mixingLIPSHITZ, Jay; CHELLIAH, Thandavababu; ALEDORT, Louis et al.American journal of hematology. 2012, Vol 87, Num 3, pp 313-315, issn 0361-8609, 3 p.Article

Thrombin-induced platelet factor V_a formation in patients with a gray platelet syndromeBARUCH, D; LINDHOUT, T; DUPUY, E et al.Thrombosis and haemostasis. 1987, Vol 58, Num 2, pp 768-771, issn 0340-6245Article

Factor V inhibitor in celiac diseaseTAILLAN, B; FUZZBET, J.-B; VINTI, H et al.The American journal of medicine. 1989, Vol 87, Num 3, issn 0002-9343, 360Article

The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotypeYAMAZAKI, Tomio; OKADA, Hiromi; BALLING, Kristoffer W et al.Thrombosis and haemostasis. 2010, Vol 104, Num 4, pp 860-861, issn 0340-6245, 2 p.Article

Location of the multimerin 1 binding site in coagulation factor V : An updateJEIMY, Samira B; QUINN-ALLEN, Mary Ann; FULLER, Nola et al.Thrombosis research. 2008, Vol 123, Num 2, pp 352-354, issn 0049-3848, 3 p.Article

Abnormal formation of the prothrombinase complex: factor V deficiency and related disordersTRACY, P. B; MANN, K. G.Human pathology. 1987, Vol 18, Num 2, pp 162-169, issn 0046-8177Article

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombinZEHNDER, J. L; LEUNG, L. L. K.Blood. 1990, Vol 76, Num 10, pp 2011-2016, issn 0006-4971Article

The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chainMARQUETTE, K. A; PITTMAN, D. D; KAUFMAN, R. J et al.Blood. 1995, Vol 86, Num 8, pp 3026-3034, issn 0006-4971Article

Severe bleeding caused by an inhibitor to coagulation factor V: a case reportSMID, W. M; DE WOLF, J. T. M; NIJLAND, J. H et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 1, pp 133-137, issn 0957-5235Article

Deficiencia del factor V (parahemofilia) en una familia mexicana. Primer informe de Mexico = Déficit du facteur V (parahémophilie) chez une famille mexicaine. Première communication à Mexico = Coagulation factor V deficiency in a Mexican familyAMBRIZ-FERNANDEZ, R; REYNA-FREGOSO, M. P; CHAVEZ SANCHEZ, G et al.Revista de investigacion clinica. 1985, Vol 37, Num 3, pp 241-244, issn 0034-8376Article

Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome : A population-based studyBENFIELD, Thomas L; DAHL, Mortens; NORDESTGAARD, Barge G et al.The Journal of infectious diseases. 2005, Vol 192, Num 10, pp 1851-1857, issn 0022-1899, 7 p.Article

Factor V^Leiden and thrombophiliaKALAFATIS, M; MANN, K. G.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 4, pp 620-627, issn 1079-5642Article

Characterization of an acquired inhibitor to coagulation factor V : antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityORTEL, T. L; QUINN-ALLEN, M. A; CHARLES, L. A et al.The Journal of clinical investigation. 1992, Vol 90, Num 6, pp 2340-2347, issn 0021-9738Conference Paper

Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasminKANE, W. H; DAVIE, E. W.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 18, pp 6800-6804, issn 0027-8424Article

EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIIIZHENG, Chunlei; LIU, Hui-Hui; JIAHAI ZHOU et al.Blood. 2010, Vol 115, Num 5, pp 1081-1087, issn 0006-4971, 7 p.Article

Epitope mapping of functional domains of human factor Va with human and murine monoclonal antibodies. Evidence for the interaction of heavy chain with factor Xa and calciumANNAMALAI, A. E; KONETI RAO, A; HUI CHONG CHIU et al.Blood. 1987, Vol 70, Num 1, pp 139-146, issn 0006-4971Article

Membrane penetration of bovine factor V and Va detected by labeling with 5-iodonaphthalene-1-azideLECOMPTE, M.-F; SRIRAM KRISHNASWAMY; MANN, K. G et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 5, pp 1935-1937, issn 0021-9258Article

The regulation of human factor V by a neutrophil proteaseOATES, A. M; SALEM, H. H.Blood. 1987, Vol 70, Num 3, pp 846-851, issn 0006-4971Article

Apparition d'un anticoagulant circulant antifacteur V après intervention chirurgicale = Occurence of a factor V inhibitor after surgeryMASSIGNON, D; ROULLIT, S; ESPINOUSE, D et al.Annales françaises d'anesthésie et de réanimation. 1989, Vol 8, Num 1, pp 70-72, issn 0750-7658Article

Activation/inactivation of human factor V by plasminLEE, C. D; MANN, K. G.Blood. 1989, Vol 73, Num 1, pp 185-190, issn 0006-4971, 6 p.Article

Factor V^NewBrunswick : Ala₂₂₁-to-Val substitution results in reduced cofactor activityMURRAY, J. M; RAND, M. D; EGAN, J. O et al.Blood. 1995, Vol 86, Num 5, pp 1820-1827, issn 0006-4971Article

Loss of membrane-dependent factor va cleavage : a mechanistic interpretation of the pathology of protein CDESHUN LU; KALAFATIS, M; MANN, K. G et al.Blood. 1994, Vol 84, Num 3, pp 687-690, issn 0006-4971Article

Platelet coagulation factor Va : the major secretory platelet phosphoproteinRAND, M. D; KALAFATIS, M; MANN, K. G et al.Blood. 1994, Vol 83, Num 8, pp 2180-2190, issn 0006-4971Article

Role of the B domain for factor VIII and factor V expression and functionPITTMAN, D. D; MARQUETTE, K. A; KAUFMAN, R. J et al.Blood. 1994, Vol 84, Num 12, pp 4214-4225, issn 0006-4971Article

Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein CHEEB, M. J; MESTERS, R. M; TANS, G et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 4, pp 2872-2877, issn 0021-9258Article